Oncology & Cancer

New target for aggressive bladder cancer

An international team of scientists have discovered a faulty process in certain bladder cancers that could point to new ways to treat patients with an aggressive form of the disease.

Oncology & Cancer

Clinical trial could lead to new bladder cancer drug

A bladder cancer drug tested in a University of Hawai'i Cancer Center clinical trial is getting closer to Food and Drug Administration (FDA) approval. The new drug, an interleukin 15 superagonist complex (ALT-803), combined ...

Oncology & Cancer

Chemo - radiation best for bladder cancer, study finds

(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Oncology & Cancer

What you need to know about bladder cancer

Bladder cancer accounts for 5 percent of all new cancer diagnoses in the U.S. with nearly 77,000 new cases annually; 1,100 people died of bladder cancer in Kentucky between 2010 and 2014.

Medical research

Study sheds new light on the growth of bladder cancer

New Curtin University-led research has discovered that using drugs to target a pathway in the body that causes cancerous cells to spread aggressively may help to reduce the severity of bladder cancer.

page 2 from 8